Axinn partner Chad Landmon was quoted in Law360’s article, “Attorneys React To High Court’s Gene Patent Ruling.” In the article, attorneys from leading law firms discuss how the U.S. Supreme Court’s recent ruling that human genes cannot be patented will affect Myriad Genetic Inc.’s patents on isolated DNA associated with an increased risk of breast cancer.

Click here to view article.